Historical record - last NADAC effective date: 7/31/2020
Product Information
NEO-SYNALAR 0.5%-0.025% CREAM is a brand (anda) product labeled by Medimetriks Pharmaceuticals Inc., priced at $13.2101 per GM under NDC 43538094060. Its NADAC has been published 261 times since Jul 20, 2016.
FDA first approved this application before 1982.
Strength
.25; 3.5 mg/g; mg/g
Manufacturer
Medimetriks Pharmaceuticals Inc.NDC
43538094060
Classification
Brand (ANDA)
Dosage Form
CREAM
Route
TOPICAL
Effective Date
7/31/2020
Active Ingredients
FLUOCINOLONE ACETONIDE; NEOMYCIN SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA060700FDA Approved
Before 1982
On Market Since
6/11/1963
Pharmacological Classes
Price Statistics
The NADAC for NEO-SYNALAR 0.5%-0.025% CREAM has been published 261 times since Jul 20, 2016, and over the history we have for it it has risen 59.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $13.2101 per GM |
|---|---|
| All-time high | $13.2101 (Jul 14, 2021) |
| All-time low | $8.2849 (Jul 20, 2016) |
| Median price | $10.3028 |
| Average price | $10.8611 |
| Largest weekly change | +12.0% (Oct 9, 2019) |
| Weeks tracked | 261 |
| Tracking since | Jul 20, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+59.4%
Last surveyed Jul 14, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the neomycin sulfate and fluocinolone acetonide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Medimetriks Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
neomycin sulfate and fluocinolone acetonide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoglycoside Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NEO-SYNALAR 0.5%-0.025% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for NEO-SYNALAR 0.5%-0.025% CREAM, manufactured by Medimetriks Pharmaceuticals Inc., is $13.2101 per GM (NDC 43538094060), effective Jul 14, 2021.
How has the price of NEO-SYNALAR 0.5%-0.025% CREAM changed over time?
Over the history we have for it, the NADAC for NEO-SYNALAR 0.5%-0.025% CREAM has risen 59.4%. It has been tracked across 261 weekly CMS publications since Jul 20, 2016.
What are the highest and lowest recorded NADAC prices for NEO-SYNALAR 0.5%-0.025% CREAM?
Since Jul 20, 2016, the NADAC for NEO-SYNALAR 0.5%-0.025% CREAM has ranged from a low of $8.2849 (Jul 20, 2016) to a high of $13.2101 (Jul 14, 2021), with a median of $10.3028 per GM.
Are there cheaper alternatives to NEO-SYNALAR 0.5%-0.025% CREAM?
No other NADAC-published product currently shares the active ingredient and strength of NEO-SYNALAR 0.5%-0.025% CREAM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NEO-SYNALAR 0.5%-0.025% CREAM?
NEO-SYNALAR 0.5%-0.025% CREAM (NDC 43538094060) is labeled by Medimetriks Pharmaceuticals Inc., and CMS classifies it as a brand (anda) product.